Corcept Therapeutics Inc - ESG Rating & Company Profile powered by AI
The article contains a questions and answers table for Corcept Therapeutics Inc. Check the end of the page for potential risks for Corcept Therapeutics Inc based on industry, location and size. If you work at Corcept Therapeutics Inc and you would like to use your Sustainability aseessment, please get in touch.
Corcept Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.8; made up of an environmental score of 0.0, social score of 1.1 and governance score of 1.3.
0.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1827 | Vaishali Pharma Ltd | 0.9 | Low |
1827 | Waverley Pharma Inc | 0.9 | Low |
1894 | Corcept Therapeutics Inc | 0.8 | Low |
1894 | Patheon BV | 0.8 | Low |
1894 | Chongqing Zhifei Biological Products Co Ltd | 0.8 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Corcept Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Corcept Therapeutics Inc disclose current and historical energy intensity?
Does Corcept Therapeutics Inc report the average age of the workforce?
Does Corcept Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does Corcept Therapeutics Inc disclose its ethnicity pay gap?
Does Corcept Therapeutics Inc disclose cybersecurity risks?
Does Corcept Therapeutics Inc offer flexible work?
Does Corcept Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Corcept Therapeutics Inc disclose the number of employees in R&D functions?
Does Corcept Therapeutics Inc conduct supply chain audits?
Does Corcept Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Corcept Therapeutics Inc conduct 360 degree staff reviews?
Does Corcept Therapeutics Inc disclose the individual responsible for D&I?
Does Corcept Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Corcept Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does Corcept Therapeutics Inc disclose water use targets?
Does Corcept Therapeutics Inc have careers partnerships with academic institutions?
Did Corcept Therapeutics Inc have a product recall in the last two years?
Does Corcept Therapeutics Inc disclose incidents of discrimination?
Does Corcept Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Corcept Therapeutics Inc issued a profit warning in the past 24 months?
Does Corcept Therapeutics Inc disclose parental leave metrics?
Does Corcept Therapeutics Inc disclose climate scenario or pathway analysis?
Does Corcept Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Corcept Therapeutics Inc disclose the pay ratio of women to men?
Does Corcept Therapeutics Inc support suppliers with sustainability related research and development?
Does Corcept Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Corcept Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Corcept Therapeutics Inc involved in embryonic stem cell research?
Does Corcept Therapeutics Inc disclose GHG and Air Emissions intensity?
Does Corcept Therapeutics Inc disclose its waste policy?
Does Corcept Therapeutics Inc report according to TCFD requirements?
Does Corcept Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Corcept Therapeutics Inc disclose energy use targets?
Does Corcept Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Corcept Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Corcept Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.